Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ... New England journal of medicine 369 (18), 1691-1703, 2013 | 6719 | 2013 |
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ... New England Journal of Medicine 381 (4), 317-327, 2019 | 1995 | 2019 |
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience AJM Ferreri, JY Blay, M Reni, F Pasini, M Spina, A Ambrosetti, ... Journal of Clinical Oncology 21 (2), 266-272, 2003 | 912 | 2003 |
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial AJM Ferreri, M Reni, M Foppoli, M Martelli, GA Pangalis, M Frezzato, ... The Lancet 374 (9700), 1512-1520, 2009 | 765* | 2009 |
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer L De Monte, M Reni, E Tassi, D Clavenna, I Papa, H Recalde, M Braga, ... Journal of Experimental Medicine 208 (3), 469-478, 2011 | 743 | 2011 |
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ... Journal of clinical oncology 24 (16), 2563-2569, 2006 | 627 | 2006 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the … AJM Ferreri, K Cwynarski, E Pulczynski, M Ponzoni, M Deckert, LS Politi, ... The Lancet Haematology 3 (5), e217-e227, 2016 | 545 | 2016 |
Meningioma C Marosi, M Hassler, K Roessler, M Reni, M Sant, E Mazza, C Vecht Critical reviews in oncology/hematology 67 (2), 153-171, 2008 | 529 | 2008 |
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ... The Lancet Oncology 17 (11), 1521-1532, 2016 | 491 | 2016 |
A multicenter study of treatment of primary CNS lymphoma AJM Ferreri, M Reni, F Pasini, A Calderoni, U Tirelli, A Pivnik, GM Aondio, ... Neurology 58 (10), 1513-1520, 2002 | 438 | 2002 |
Intra-and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning C Fiorino, M Reni, A Bolognesi, GM Cattaneo, R Calandrino Radiotherapy and oncology 47 (3), 285-292, 1998 | 423 | 1998 |
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial M Reni, S Cordio, C Milandri, P Passoni, E Bonetto, C Oliani, G Luppi, ... The lancet oncology 6 (6), 369-376, 2005 | 339 | 2005 |
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS … AJM Ferreri, K Cwynarski, E Pulczynski, CP Fox, E Schorb, P La Rosée, ... The Lancet Haematology 4 (11), e510-e523, 2017 | 318 | 2017 |
Glioblastoma in adults AA Brandes, A Tosoni, E Franceschi, M Reni, G Gatta, C Vecht Critical reviews in oncology/hematology 67 (2), 139-152, 2008 | 266 | 2008 |
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature M Reni, AJM Ferreri, MP Garancini, E Villa Annals of Oncology 8 (3), 227-234, 1997 | 242 | 1997 |
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial M Reni, G Balzano, S Zanon, A Zerbi, L Rimassa, R Castoldi, D Pinelli, ... The lancet Gastroenterology & hepatology 3 (6), 413-423, 2018 | 223 | 2018 |
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent … AA Brandes, A Tosoni, G Cavallo, M Reni, E Franceschi, L Bonaldi, ... Journal of clinical oncology 24 (29), 4746-4753, 2006 | 222 | 2006 |
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. GL Ceresoli, M Reni, G Chiesa, A Carretta, S Schipani, P Passoni, ... Cancer 95 (3), 605-612, 2002 | 212 | 2002 |
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma F Marchesi, L Piemonti, G Fedele, A Destro, M Roncalli, L Albarello, ... Cancer research 68 (21), 9060-9069, 2008 | 203 | 2008 |
Ependymoma M Reni, G Gatta, E Mazza, C Vecht Critical reviews in oncology/hematology 63 (1), 81-89, 2007 | 202 | 2007 |